Pharma News

The European Commission has granted marketing authorization to Cara Therapeutics’ and Vifor Pharma’s Kapruvia (difelikefalin) for the treatment of patients with moderate-to-severe pruritus asso...

LianBio said Friday that Bristol Myers Squibb got U.S. Food and Drug Administration approval for Camzyos mavacamten capsules for the treatment of adults with symptomatic class II-III obstructive hy...

The US Food and Drug Administration (FDA) has granted Fast Track Designation for SQZ Biotechnologies’ lead cell therapy candidate, SQZ-PBMC-HPV, for treating HPV16+ advanced or metastatic solid t...

C. Michael White, Professor of Pharmacy Practice, University of Connecticut: Many over-the-counter dietary supplement products — especially those used for sexual enhancement and weight loss — a...

The FDA has granted AstraZeneca’s and Daiichi Sankyo’s antibody drug conjugate Enhertu (trastuzumab deruxtecan) a fifth Breakthrough Therapy designation for patients with unresectable or metas...

The European Commission has granted a marketing authorization for Pfizer’s and Biohaven Pharmaceutical’s oral migraine drug Vydura (rimegepant).

Follow-on collaboration between ViGeneron and Daiichi Sankyo allows the companies to create and validate vgAAV-based therapeutic candidates.

New research published in Neurology and Therapy suggests that treatment with anti-amyloid-beta protofibril antibody lecanemab (BAN2401) is estimated to slow the rate of disease progression in patie...

On Monday, Nektar Therapeutics outlined a strategic reorganization plan that includes cutting 70% of its workforce. 

The public image of drugmakers has improved significantly during the pandemic, according to the latest annual survey by PatientView, a UK-based research and consulting firm. ...

Pfizer has recalled five lots of Accupril (Quinapril HCl), its blood pressure adjunctive therapy for heart failure, due to the presence of unacceptable levels of a nitrosamine. ...

Valneva said the European Medicines Agency (EMA) has asked for more data on the company’s COVID-19 vaccine candidate, VLA2001, which the agency is reviewing for a possible marketing authorization...